Literature DB >> 15504824

Chloroquine resistance in Plasmodium vivax.

J Kevin Baird1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15504824      PMCID： PMC525399          DOI： 10.1128/AAC.48.11.4075-4083.2004

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  106 in total

1.  Molecular analysis of strains of Plasmodium vivax from paired primary and relapse infections.

Authors:  A A Craig; K C Kain
Journal:  J Infect Dis       Date:  1996-08       Impact factor: 5.226

2.  Blood levels and in vitro activity of desethylchloroquine against Plasmodium falciparum.

Authors:  F Verdier; J Le Bras; F Clavier; I Hatin
Journal:  Lancet       Date:  1984-05-26       Impact factor: 79.321

3.  Survey of resistance to chloroquine by Plasmodium vivax in Indonesia.

Authors:  J K Baird; M F Sustriayu Nalim; H Basri; S Masbar; B Leksana; E Tjitra; R M Dewi; M Khairani; F S Wignall
Journal:  Trans R Soc Trop Med Hyg       Date:  1996 Jul-Aug       Impact factor: 2.184

4.  Plasmodium vivax clinically resistant to chloroquine in Colombia.

Authors:  J Soto; J Toledo; P Gutierrez; M Luzz; N Llinas; N Cedeño; M Dunne; J Berman
Journal:  Am J Trop Med Hyg       Date:  2001-08       Impact factor: 2.345

5.  In-vivo sensitivity of Plasmodium vivax isolates from Rond nia (western Amazon region, Brazil) to regimens including chloroquine and primaquine.

Authors:  J M Villalobos-Salcedo; M S Tada; E Kimura; M J Menezes; L H Pereira da Silva
Journal:  Ann Trop Med Parasitol       Date:  2000-12

6.  COMPARISON OF CHLOROQUINE, QUINACRINE (ATABRINE), AND QUININE IN THE TREATMENT OF ACUTE ATTACKS OF SPOROZOITE-INDUCED VIV AX MALARIA (CHESSON STRAIN).

Authors:  T N Pullman; B Craige; A S Alving; C M Whorton; R Jones; L Eichelberger
Journal:  J Clin Invest       Date:  1948-05       Impact factor: 14.808

7.  Chloroquine for the treatment of uncomplicated malaria in Guyana.

Authors:  J K Baird; T Tiwari; G J Martin; C L Tamminga; T M Prout; J Tjaden; P P Bravet; S Rawlins; M Ferrel; D Carucci; S L Hoffman
Journal:  Ann Trop Med Parasitol       Date:  2002-06

8.  The single dose kinetics of chloroquine and its major metabolite desethylchloroquine in healthy subjects.

Authors:  M Frisk-Holmberg; Y Bergqvist; E Termond; B Domeij-Nyberg
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

9.  Chloroquine and desethylchloroquine in plasma, serum, and whole blood: problems in assay and handling of samples.

Authors:  L Rombo; O Ericsson; G Alván; B Lindström; L L Gustafsson; F Sjöqvist
Journal:  Ther Drug Monit       Date:  1985       Impact factor: 3.681

10.  Chloroquine-resistant Plasmodium vivax malaria in Peru.

Authors:  Trenton K Ruebush; Jorge Zegarra; Javier Cairo; Ellen M Andersen; Michael Green; Dylan R Pillai; Wilmer Marquiño; María Huilca; Ernesto Arévalo; Coralith Garcia; Lely Solary; Kevin C Kain
Journal:  Am J Trop Med Hyg       Date:  2003-11       Impact factor: 2.345
View more
  137 in total

1.  Sensitivity of Plasmodium vivax to chloroquine, mefloquine, artemisinin and atovaquone in north-western Thailand.

Authors:  Moritz Treiber; Gunther Wernsdorfer; Ursula Wiedermann; Kanungnit Congpuong; Jeeraphat Sirichaisinthop; Walther H Wernsdorfer
Journal:  Wien Klin Wochenschr       Date:  2011-09-22       Impact factor: 1.704

2.  Synergism between pyronaridine and retinol in Plasmodium vivax in vitro.

Authors:  Julia Riedl; Gunther Wernsdorfer; Kanungnit Congpuong; Ursula Wiedermann; Jeeraphat Sirichaisinthop; Walther H Wernsdorfer
Journal:  Wien Klin Wochenschr       Date:  2010-10       Impact factor: 1.704

3.  Prevention and treatment of vivax malaria.

Authors:  J Kevin Baird; Eli Schwartz; Stephen L Hoffman
Journal:  Curr Infect Dis Rep       Date:  2007-01       Impact factor: 3.725

4.  In vitro activity of pyronaridine against multidrug-resistant Plasmodium falciparum and Plasmodium vivax.

Authors:  R N Price; J Marfurt; F Chalfein; E Kenangalem; K A Piera; E Tjitra; N M Anstey; B Russell
Journal:  Antimicrob Agents Chemother       Date:  2010-09-27       Impact factor: 5.191

5.  Usefulness of the recombinant liver stage antigen-3 for an early serodiagnosis of Plasmodium falciparum infection.

Authors:  Hyeong-Woo Lee; Sung-Ung Moon; Hye-Sun Ryu; Yeon-Joo Kim; Shin-Hyeong Cho; Gyung-Tae Chung; Khin Lin; Byoung-Kuk Na; Yoon Kong; Kyung-Suk Chung; Tong-Soo Kim
Journal:  Korean J Parasitol       Date:  2006-03       Impact factor: 1.341

6.  In vitro anti-malarial drug susceptibility of temperate Plasmodium vivax from central China.

Authors:  Feng Lu; Qi Gao; Kesinee Chotivanich; Hui Xia; Jun Cao; Rachanee Udomsangpetch; Liwang Cui; Jetsumon Sattabongkot
Journal:  Am J Trop Med Hyg       Date:  2011-08       Impact factor: 2.345

7.  Clinical efficacy of chloroquine versus artemether-lumefantrine for Plasmodium vivax treatment in Thailand.

Authors:  Srivicha Krudsood; Noppadon Tangpukdee; Sant Muangnoicharoen; Vipa Thanachartwet; Nutthanej Luplertlop; Siripan Srivilairit; Polrat Wilairatana; Shigeyuki Kano; Pascal Ringwald; Sornchai Looareesuwan
Journal:  Korean J Parasitol       Date:  2007-06       Impact factor: 1.341

8.  Genetic Variation of MSP-1 Gene in Plasmodium vivax Isolated from Patients in Hormozgan Province, Iran using SSCP-PCR.

Authors:  A Miahipour; H Keshavarz; A Heidari; A Raeisi; M Rezaeian; S Rezaie
Journal:  Iran J Parasitol       Date:  2012       Impact factor: 1.012

9.  Randomized, open-label trial of primaquine against vivax malaria relapse in Indonesia.

Authors:  Inge Sutanto; Bagus Tjahjono; Hasan Basri; W Robert Taylor; Fauziah A Putri; Rizka A Meilia; Rianto Setiabudy; Siti Nurleila; Lenny L Ekawati; Iqbal Elyazar; Jeremy Farrar; Herawati Sudoyo; J Kevin Baird
Journal:  Antimicrob Agents Chemother       Date:  2012-12-17       Impact factor: 5.191

10.  Pharmacokinetics of hydroxychloroquine and its clinical implications in chemoprophylaxis against malaria caused by Plasmodium vivax.

Authors:  Hyeong-Seok Lim; Jeong-Soo Im; Joo-Youn Cho; Kyun-Seop Bae; Terry A Klein; Joon-Sup Yeom; Tae-Seon Kim; Jae-Seon Choi; In-Jin Jang; Jae-Won Park
Journal:  Antimicrob Agents Chemother       Date:  2009-02-02       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.